| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | canertinib | CTRPv2 | pan-cancer | AAC | -0.0064 | 0.9 |
| mRNA | navitoclax:PLX-4032 (1:1 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.0062 | 0.9 |
| mRNA | AZD-2281 | FIMM | pan-cancer | AAC | 0.025 | 0.9 |
| mRNA | RAF265 | CTRPv2 | pan-cancer | AAC | -0.0071 | 0.9 |
| mRNA | BRD-K13185470 | CTRPv2 | pan-cancer | AAC | -0.012 | 0.9 |
| mRNA | paclitaxel | UHNBreast | pan-cancer | AAC | -0.049 | 0.9 |
| mRNA | GDC-0941 | gCSI | pan-cancer | AAC | 0.011 | 0.9 |
| mRNA | ABT-263 | CTRPv2 | pan-cancer | AAC | -0.0056 | 0.9 |
| mRNA | Mitomycin-C | CTRPv2 | pan-cancer | AAC | 0.0051 | 0.9 |
| mRNA | cimetidine | CTRPv2 | pan-cancer | AAC | -0.01 | 0.9 |